Results 41 to 50 of about 160,524 (198)
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder caused by hypersensi- tivity to Aspergillus fumigatus. The diagnosis is based on sensitization to Aspergillus, associated with clinical, immunological and radiological ...
Arturi, Elisa +6 more
core +1 more source
Impact of
For decades, fungi have been recognized as associated with asthma and other reactive airway diseases. In contrast to type I-mediated allergies caused by pollen, fungi cause a large number of allergic diseases such as allergic bronchopulmonary mycoses ...
Chaudhary Neelkamal, Marr Kieren A
doaj +1 more source
Endobronchial Aspergillosis Presenting as an Isolated Airway Lesion in an Immunocompromised Patient
Endobronchial Aspergillus infection should be considered in immunocompromised patients presenting with airway obstruction, even in the absence of parenchymal lung involvement. This case highlights the potential for rapid clinical deterioration and the diagnostic challenges in distinguishing endobronchial aspergillosis from more aggressive forms of ...
Mohsen Sadeghi +3 more
wiley +1 more source
Pediatric Pulmonary and Thoracic Aspergillosis
Aspergillus infection can cause significant disease in an immunocompromised host and lungs are the most common site of infection. Various forms of aspergillus involving lung parenchyma have been described including aspergilloma, allergic bronchopulmonary
Preeyacha Pacharn +3 more
doaj
We present a patient with long‐standing severe Type 2 asthma complicated by recurrent exacerbations of an infective nature that was ultimately found to be associated with gastric band slippage causing gastric stenosis and delayed gastric emptying. Exacerbations ceased after surgical intervention and removal of the band.
Gerardo Arwi +2 more
wiley +1 more source
Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked ...
Thomas J. Walsh +3 more
core +1 more source
Species within the Aspergillus spp. cause a wide range of infections in humans, including invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, and allergic bronchopulmonary aspergillosis, and are associated with high mortality rates.
Liuyang Cai +14 more
doaj +1 more source
IL‐33 induces inflammatory gene signatures in eosinophils, characterised by the upregulation of cell surface markers, inflammatory mediators and regulatory factors, all of which were also observed in nasal polyp‐derived eosinophils. Ox‐LDL and complement fragments (C3a and C5a) promote eosinophil adhesion and survival.
Emiko Matsuyama +16 more
wiley +1 more source
Studies suggest that type 2 inflammatory diseases are driven by overactivation of the IL4/IL13 pathway, manifesting differently in distinct tissues. We performed quantitative analyses using several large independent datasets to explore the interrelation of type 2 inflammatory diseases based on co‐prevalence, genetic predispositions, and transcriptomic ...
Jennifer D. Hamilton +19 more
wiley +1 more source
Allergic Bronchopulmonary Aspergillosis masquerading as recurrent bacterial pneumonia
Allergic Bronchopulmonary Aspergillosis (ABPA) can be diagnosed in an asthmatic with suitable radiologic and immunological features. However ABPA is likely to be misdiagnosed with bacterial pneumonia.
Ngoc Tran Van +2 more
core +1 more source

